Industrial Advisory Board

As part of our exploitation strategy we promote an active network with industry stakeholders within the framework of our so-called Industrial Advisory board (IAB) to

• keep up with the scientific and industrial development of project-related innovative technologies and appropriate standards that are responsive to the constant changes in the scientific environment.
• receive industrie's advice on technology and product innovation to identify exploitation trends that will position the StemCellFactory to meet the future challenges.
• sustain a forum for scientific, technical and economic exchange between academia and industry based on the objectives and deliverables of the StemCellFactory project.
• develop a technology roadmap that secures a market-driven further (co)-development of the project results.

Key objectives of the StemCellFactory III project:

• Fully automated reprogramming of peripheral blood mononuclear cells derived from patient blood samples
• Fully automated genome editing using CRISPR/Cas technology
• GMP compliant risk, data and quality management for automated cell production
• Scalable production of iPS cell-derived neuronal organoids
• Metabolic assay development

If you are interested in serving on our IAB, please feel free to contact Kai Rahnenführer via email (kai.rahnenfuehrer@p3-group.com) for more information.

INDUSTRIAL ADVISORY BOARD CONTACT

Dipl.-Ing. Kai Rahnenführer

Geschäftsführer/ Gesellschafter

P3 group GmbH
Am Kraftversorgungsturm 3
52070 Aachen

E-Mail: kai.rahnenfuehrer@p3-group.com

Homepage: https://www.p3-group.com/branchen/aviation/